CRBP icon

Corbus Pharmaceuticals

69 hedge funds and large institutions have $101M invested in Corbus Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

13% less capital invested

Capital invested by funds: $116M → $101M (-$15M)

19% less call options, than puts

Call options by funds: $2.19M | Put options by funds: $2.71M

Holders
69
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.19M
Puts
$2.71M
Net Calls
Net Calls Change

Top Buyers

1 +$11.3M
2 +$3.59M
3 +$2.71M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.94M
5
AG
Artal Group
Luxembourg
+$1.57M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$23.6M
2
$15.5M
3
$9.85M
4
$7.76M
5
$6.31M
6
$5.78M
7
$4.41M
8
$3.71M
9
$3.04M
10
$2.69M
11
$1.78M
12
$1.57M
13
$1.19M
14
$1.09M
15
$952K
16
$904K
17
$862K
18
$820K
19
$761K
20
$760K
21
$686K
22
$503K
23
$495K
24
$469K
25
$464K